Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Johnson & Johnson's COVID-19 vaccine under scrutiny at EMA after 4 'serious cases' of unusual blood clots
3 major health items included in President Biden's budget request
COVID-19 tracker: Pfizer asks U.S. to expand vax nod to adolescents; EU eyes deal for 1.8B Pfizer-BioNTech doses
Emergent's Baltimore plant flagged for quality control concerns last April, FDA report reveals
Biotech internships in a pandemic? Diversity-boosting Project Onramp adjusts to COVID-19, moves into Philadelphia, plots further expansion
UPDATED Coronavirus tracker: Americans' opinions about telehealth have changed due to COVID-19, survey finds
CMS proposes 1.3% pay bump for skilled nursing facilities, several new quality measures

Featured Story

Johnson & Johnson's COVID-19 vaccine under scrutiny at EMA after 4 'serious cases' of unusual blood clots

By Eric Sagonowsky

AstraZeneca’s COVID-19 vaccine has dominated headlines as reports of rare blood clots mounted, but, now, European drug safety regulators are investigating potential clotting risks from Johnson & Johnson’s vaccine. Like AstraZeneca's, the J&J shot is adenovirus-based.

3 major health items included in President Biden's budget request

By Robert King

President Biden made a major budget request to Congress that includes new funding for public health and to fight the opioid epidemic.

COVID-19 tracker: Pfizer asks U.S. to expand vax nod to adolescents; EU eyes deal for 1.8B Pfizer-BioNTech doses

By Kevin Dunleavy,Fraiser Kansteiner,Eric Sagonowsky

Pfizer has asked the U.S. to expand the emergency authorization of its vaccine to adolescents aged 12 to 15. The European Union is in talks with Pfizer and BioNTech for 1.8 billion more vaccine doses. Germany is negotiating with Russia for its Sputnik V vaccine. And more headlines.

Emergent's Baltimore plant flagged for quality control concerns last April, FDA report reveals

By Fraiser Kansteiner

An FDA Form 483 has illuminated problems at Emergent BioSolution's Baltimore manufacturing site, where the CDMO recently had to scrap some 15 million Johnson & Johnson COVID-19 vaccine doses over a production error. Thing is, the FDA flagged Emergent for very similar issues almost a year ago.

Biotech internships in a pandemic? Diversity-boosting Project Onramp adjusts to COVID-19, moves into Philadelphia, plots further expansion

By Amirah Al Idrus

Project Onramp kicked off in 2019 to connect low-income students across Massachussetts to well-paid summer internships at local biotech companies. Since then, the internship program has weathered the COVID-19 pandemic, connected students and companies outside of Massachusetts through virtual internships and expanded into a new city: Philadelphia.

UPDATED Coronavirus tracker: Americans' opinions about telehealth have changed due to COVID-19, survey finds

By Healthcare Staff

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

CMS proposes 1.3% pay bump for skilled nursing facilities, several new quality measures